CompletedEUCTR 2021-001174-29
Effectiveness of methylphenidate in adults with phenylketonuria and attention-deficit/hyperactivity disorder: An N-of-1 series
This historical record does not confirm current site availability.
Historical research recordNetherlandsADHD
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who was this study for?
This study was for people with ADHD. Other eligibility criteria applied.
- Listed locations
- Netherlands
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Amsterdam UMC
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Netherlands
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2021-001174-29
- Official title
Show the full official title
Effectiveness of methylphenidate in adults with phenylketonuria and attention-deficit/hyperactivity disorder: An N-of-1 series
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Netherlands
Registry details
Historical country statuses
- Netherlands — Completed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Amsterdam UMC.
Who was this study for?
This study was for people with ADHD. Other eligibility criteria applied.
